Search details
1.
Targeting Wnt-ß-Catenin-FOSL Signaling Ameliorates Right Ventricular Remodeling.
Circ Res
; 132(11): 1468-1485, 2023 05 26.
Article
in English
| MEDLINE | ID: mdl-37042252
2.
CILP1 as a biomarker for right ventricular maladaptation in pulmonary hypertension.
Eur Respir J
; 57(4)2021 04.
Article
in English
| MEDLINE | ID: mdl-33184116
3.
SPARCL1 as a biomarker of maladaptive right ventricular remodelling in pulmonary hypertension.
Biomarkers
; 25(3): 290-295, 2020 May.
Article
in English
| MEDLINE | ID: mdl-32248722
4.
Allele-specific quantitative proteomics unravels molecular mechanisms modulated by cis-regulatory PPARG locus variation.
Nucleic Acids Res
; 45(6): 3266-3279, 2017 04 07.
Article
in English
| MEDLINE | ID: mdl-28334807
5.
Fibroblast growth factor 23 as a biomarker of right ventricular dysfunction in pulmonary hypertension.
Clin Res Cardiol
; 112(10): 1382-1393, 2023 Oct.
Article
in English
| MEDLINE | ID: mdl-36790465
6.
CILP1 as a biomarker for right ventricular dysfunction in patients with ischemic cardiomyopathy.
Pulm Circ
; 12(1): e12062, 2022 Jan.
Article
in English
| MEDLINE | ID: mdl-35506075
7.
GDF-15 and soluble ST2 as biomarkers of right ventricular dysfunction in pulmonary hypertension.
Biomark Med
; 16(17): 1193-1207, 2022 12.
Article
in English
| MEDLINE | ID: mdl-36790217
8.
Osteopontin and galectin-3 as biomarkers of maladaptive right ventricular remodeling in pulmonary hypertension.
Biomark Med
; 15(12): 1021-1034, 2021 08.
Article
in English
| MEDLINE | ID: mdl-34289706
9.
National and sub-national burden of chronic diseases attributable to lifestyle risk factors in Iran 1990 - 2013; study protocol.
Arch Iran Med
; 17(3): 146-58, 2014 Mar.
Article
in English
| MEDLINE | ID: mdl-24621357
Results
1 -
9
de 9
1
Next >
>>